Pancreatic gene therapy durably improves glycaemia and delays disease progression in a murine model of type 2 diabetes

被引：0
|
作者：
Rajagopalan, H. [1 ]
Lubaczeuski, C. [1 ]
Cozzi, E. [1 ]
Picard, N. [1 ]
Wainer, J. [1 ]
Reese, R. [1 ]
Caplan, J. [1 ]
West, J. [1 ]
Liou, A. P. [1 ]
机构：
[1] Fractyl Hlth Inc, Lexington, MA USA
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
100
引用
收藏
页码：S54 / S55
页数：2
相关论文
共 50 条
  • [21] Modifying the timing of breakfast improves postprandial glycaemia in people with type 2 diabetes: A randomised controlled trial
    Bravo-Garcia, Ana Paula
    Reddy, Anjana J.
    Radford, Bridget E.
    Hawley, John A.
    Parr, Evelyn B.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (11-12)
  • [22] Identification of a pancreatic stellate cell gene signature and lncRNA interactions associated with type 2 diabetes progression
    Qiu, Jinjun
    Zhu, Peng
    Shi, Xing
    Xia, Jinquan
    Dong, Shaowei
    Chen, Liqun
    FRONTIERS IN ENDOCRINOLOGY, 2025, 15
  • [23] Gene therapy for type 1 and type 2 diabetes
    Leibowitz, G
    Levine, F
    DIABETES REVIEWS, 1999, 7 (02): : 124 - 138
  • [24] Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease
    Whiting, Rebecca E. H.
    Jensen, Cheryl A.
    Pearce, Jacqueline W.
    Gillespie, Lauren E.
    Bristow, Daniel E.
    Katz, Martin L.
    EXPERIMENTAL EYE RESEARCH, 2016, 146 : 276 - 282
  • [25] Ex vivo gene therapy improves the accumulation of glycosaminoglycans in brain from murine model of mucopolysaccharidosis type II
    Wakabayashi, Taichi
    Shimada, Yohta
    Higuchi, Takashi
    Kobayashi, Hiroshi
    Ida, Hiroyuki
    Ohashi, Toya
    GLYCOBIOLOGY, 2014, 24 (11) : 1214 - 1214
  • [26] Immuno-gene therapy with interferon-β before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma
    Kruklitis, RJ
    Singhal, S
    Delong, P
    Kapoor, V
    Sterman, DH
    Kaiser, LR
    Albelda, SM
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (01): : 123 - 130
  • [27] Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
    Wanner, Christoph
    Inzucchi, Silvio E.
    Lachin, John M.
    Fitchett, David
    von Eynatten, Maximilian
    Mattheus, Michaela
    Johansen, Odd Erik
    Woerle, Hans J.
    Broedl, Uli C.
    Zinman, Bernard
    Aizenberg, D.
    Ulla, M.
    Waitman, J.
    De Loredo, L.
    Farias, J.
    Fideleff, H.
    Lagrutta, M.
    Maldonado, N.
    Colombo, H.
    Ferre Pacora, F.
    Wasserman, A.
    Maffei, L.
    Lehman, R.
    Selvanayagam, J.
    d'Emden, M.
    Fasching, P.
    Paulweber, B.
    Toplak, H.
    Luger, A.
    Drexel, H.
    Prager, R.
    Schnack, C.
    Schernthaner, G.
    Fliesser-Goerzer, E.
    Kaser, S.
    Scheen, A.
    Van Gaal, L.
    Hollanders, G.
    Kockaerts, Y.
    Capiau, L.
    Chachati, A.
    Persu, A.
    Hermans, M.
    Vantroyen, D.
    Vercammen, C.
    Van de Borne, P.
    Mathieu, C.
    Benhalima, K.
    Lienart, F.
    Mortelmans, J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04): : 323 - 334
  • [28] Clinical predictors of disease progression in type 2 diabetes
    Pani, Lydie N.
    Grant, Richard W.
    Nathan, David M.
    DIABETES, 2007, 56 : A269 - A269
  • [29] Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
    Pareek, Anil
    Chandurkar, Nitin
    Naidu, Kumar
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (18): : 1800 - 1800
  • [30] Exenatide Improves Pancreatic Beta Cell Function in a Canine Model of Obese Mild Type 2 Diabetes
    Ionut, Viorica
    Liu, Huiwen
    Mkrtchyan, Hasmik
    Stefanovski, Darko
    Woolcott, Orison
    Castro, Ana Valeria B.
    Broussard, Josiane L.
    Kabir, Morvarid
    Iyer, Malini
    Bergman, Richard N.
    DIABETES, 2011, 60 : A483 - A483
12345